Norway vs Singapore: Hib vaccine
Norway
97
in 2025
Singapore
97
in 2025
Norway rank
32nd
Singapore rank
32nd
Hib vaccine over time
- Norway
- Singapore
How they compare
Norway currently reports 97 against 97 in Singapore, a difference of 0.
The two have swapped places 3 times across 13 shared years of data; in 2013 it was Norway ahead.
Norway ranks 32nd and Singapore ranks 32nd of 193 countries.
Across the 2 decades both report, Norway averaged higher in 1 and Singapore in 1.
Head to head by decade
| Decade | Norway | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 95.57 | 93.14 | 2.43 | Norway |
| 2020s | 96.83 | 97.5 | 0.6667 | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hib vaccine, Norway or Singapore?
- Norway, at 97 against 97 in Singapore as of 2025.
- What is the difference in hib vaccine between Norway and Singapore?
- 0, with Norway ahead.
- How many years of comparable data are there for Norway and Singapore?
- 13 years are reported by both, from 2013 to 2025.
- How do Norway and Singapore rank globally for hib vaccine?
- Norway ranks 32nd and Singapore ranks 32nd of 193 countries.
- Where does this data come from?
- Our World in Data, published as Hib vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.